The US Foods and Drugs Administration (USFDA) will be sued by the US pharmaceutical company Mylan Inc, for an injunction on the launch of Ranbaxy’s cholesterol treatment drug Aricept, which is a generic version of Pfizer’s Lipitor.
first published: Mar 21, 2011 01:05 pm
A collection of the most-viewed Moneycontrol videos.
Iran–US Conflict: Will India’s Fiscal Deficit, Rupee & Markets Take a Hit? | Centre Point
Oil Shock: India’s Oil Security at Stake | Is an LNG Shock Coming for India? | Commodities with MC
Monday Mayhem in markets| Brent surges 18%, Global markets slide 2-8% | Nifty Set for Gap Down Open
PM Modi Speech: PM Modi Accuses TMC of Insulting President Murmu and Constitution
